Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06185738 · ClinicalTrials.gov registry record · NA
WeCanManage. An mHealth Self-management Tool
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06185738 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 20 participants.
The verdict
NCT06185738, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities
Interventions
- OTHER WCM app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06185738
The ClinicalTrials.gov registry entry for NCT06185738 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which WCM app is the first listed.
NCT06185738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06185738 about?
NCT06185738 is a clinical study titled "WeCanManage. An mHealth Self-management Tool". Examine the Feasibility, Acceptability, User Satisfaction, and Response Patterns and Preliminary Efficacy on Targeted Patient Reported Outcomes. Using a pre-post, single arm feasibility design with cancer survivors with disabilities
What is the current status of trial NCT06185738?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2024-07-01. Estimated completion is 2025-08-01.
What interventions are being tested in trial NCT06185738?
The interventions under investigation include: WCM app (OTHER).
Who is sponsoring clinical trial NCT06185738?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.